This Sarepta Therapeutics Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Benzinga·1d ago
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HC Wainwright & Co. analyst Mitchell Kapoor downgraded Sarepta Therapeutics, Inc. (NASDAQ:SRPT) from Neutral to Sell and lowered the price target from $40 to $10. Sarepta Therapeutics shares closed at $18.98 on Tuesday. See how other analysts view this stock.
BTIG analyst Gregory Lewis downgraded the rating for NuScale Power Corporation (NYSE:SMR) from Buy to Neutral. NuScale Power shares closed at $43.24 on Tuesday. See how other analysts view this stock.
Goldman Sachs analyst Carly Davenport downgraded WEC Energy Group, Inc. (NYSE:WEC) from Neutral to Sell and lowered the price target from $106 to $100. WEC Energy shares closed at $105.36 on Tuesday. See how other analysts view this stock.
Macquarie analyst James Hong downgraded the rating for Honda Motor Co., Ltd. (NYSE:HMC) from Outperform to Neutral. Honda Motor shares closed at $28.88 on Tuesday. See how other analysts view this stock.
Barclays analyst Julien Roch downgraded Omnicom Group Inc. (NYSE:OMC) from Overweight to Equal-Weight and lowered the price target from $105 to $80. Omnicom Group shares closed at $72.48 on Tuesday. See how other analysts view this stock.
Considering buying SRPT stock? Here’s what analysts think:
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.